Gene expression profiling of clinical stages II and III breast cancer
AUTOR(ES)
Folgueira, M.A.A.K., Brentani, H., Katayama, M.L.H., Patrão, D.F.C., Carraro, D.M., Mourão Netto, M., Barbosa, E.M., Caldeira, J.R.F., Abreu, A.P.S., Lyra, E.C., Kaiano, J.H.L., Mota, L.D., Campos, A.H.J.F.M., Maciel, M.S., Dellamano, M., Caballero, O.L.S.D., Brentani, M.M.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2006-08
RESUMO
Clinical stage (CS) is an established indicator of breast cancer outcome. In the present study, a cDNA microarray platform containing 692 genes was used to identify molecular differences between CSII and CSIII disease. Tumor samples were collected from patients with CSII or CSIII breast cancer, and normal breast tissue was collected from women without invasive cancer. Seventy-eight genes were deregulated in CSIII tumors and 22 in CSII tumors when compared to normal tissue, and 20 of them were differentially expressed in both CSII and CSIII tumors. In addition, 58 genes were specifically altered in CSIII and expression of 6 of them was tested by real time RT-PCR in another cohort of patients with CSII or CSIII breast cancer and in women without cancer. Among these genes, MAX, KRT15 and S100A14, but not APOBEC3G or KRT19, were differentially expressed on both CSIII and CSII tumors as compared to normal tissue. Increased HMOX1 levels were detected only in CSIII tumors and may represent a molecular marker of this stage. A clear difference in gene expression pattern occurs at the normal-to-cancer transition; however, most of the differentially expressed genes are deregulated in tumors of both CS (II and III) compared to normal breast tissue.
Documentos Relacionados
- Gene expression profiling predicts clinical outcome of prostate cancer
- Expression profiling predicts outcome in breast cancer
- Cancer gene expression database (CGED): a database for gene expression profiling with accompanying clinical information of human cancer tissues
- Clinical practice guidelines for the care and treatment of breast cancer: Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update)
- Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer